He Qinglian, Long Jiali, Yin Yuting, Li Yuling, Lei Xue, Li Ziqi, Zhu Wei
Department of Pathology, Guangdong Medical University, Dongguan, China.
Department of Pathology, Dongguan Hospital of Southern Medical University, Dongguan, China.
Front Oncol. 2020 Jan 17;9:1542. doi: 10.3389/fonc.2019.01542. eCollection 2019.
Colorectal cancer (CRC) is the primary cause of cancer-related death worldwide; however, specific and sensitive tools for the early diagnosis and targeted therapy of CRC are currently lacking. High-throughput sequencing technology revealed that gene expression of long-chain non-coding RNAs (lncRNAs) in a number of cancers directly or indirectly interferes with various biological processes. Emerging evidence suggests that lncRNAs regulate target genes and play an important role in the biological processes of malignancies, including CRC. Many carcinostatic/oncogenic lncRNAs have been identified as biomarkers for metastasis and prognosis in CRC; hence, they serve as therapeutic tools. In this article, we systematically review the literature on the disordered lncRNAs in CRC from four aspects: DNA transcription, RNA level regulation, post-translational level, and the translation of lncRNAs into polypeptides. Subsequently, we analyze the mechanism through which lncRNAs participate in the biological process of CRC. Finally, we discuss the application and prospects of these lncRNAs in CRC.
结直肠癌(CRC)是全球癌症相关死亡的主要原因;然而,目前缺乏用于CRC早期诊断和靶向治疗的特异性和灵敏性工具。高通量测序技术表明,多种癌症中长链非编码RNA(lncRNAs)的基因表达直接或间接干扰各种生物学过程。新出现的证据表明,lncRNAs调节靶基因,并在包括CRC在内的恶性肿瘤生物学过程中发挥重要作用。许多抑癌/致癌lncRNAs已被鉴定为CRC转移和预后的生物标志物;因此,它们可作为治疗工具。在本文中,我们从DNA转录、RNA水平调控、翻译后水平以及lncRNAs翻译成多肽四个方面系统地综述了关于CRC中lncRNAs紊乱的文献。随后,我们分析了lncRNAs参与CRC生物学过程的机制。最后,我们讨论了这些lncRNAs在CRC中的应用和前景。